In 2023, hospital discharges for leiomyoma of the uterus in Germany stood at approximately 49.67 thousand. By 2024, the forecast suggests a decline to 48.77 thousand. The year-on-year variation indicates a consistent downward trend: a decrease of 3.42% in 2024, followed by a 3.43% reduction in 2025, 3.50% in 2026, 3.61% in 2027, and 3.70% in 2028. The compound annual growth rate (CAGR) from 2024 to 2028 is approximately -3.54% annually.

Future trends to watch for include:

Implementation of less invasive treatments, reducing the need for hospital stays.
Increased awareness and early intervention leading to fewer severe cases requiring hospital discharges.
Potential advancements in medical technology and treatment options that could alter discharge rates.